KR101060331B1 - 인플루엔자 바이러스 감염의 치료에 유용한 약제의 제조를위한 레스베라트롤의 용도 - Google Patents

인플루엔자 바이러스 감염의 치료에 유용한 약제의 제조를위한 레스베라트롤의 용도 Download PDF

Info

Publication number
KR101060331B1
KR101060331B1 KR1020057007230A KR20057007230A KR101060331B1 KR 101060331 B1 KR101060331 B1 KR 101060331B1 KR 1020057007230 A KR1020057007230 A KR 1020057007230A KR 20057007230 A KR20057007230 A KR 20057007230A KR 101060331 B1 KR101060331 B1 KR 101060331B1
Authority
KR
South Korea
Prior art keywords
resveratrol
virus
cells
infection
influenza virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020057007230A
Other languages
English (en)
Korean (ko)
Other versions
KR20050071627A (ko
Inventor
엔리코 가라시
안나 테레사 팔라마라
Original Assignee
시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. filed Critical 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이.
Publication of KR20050071627A publication Critical patent/KR20050071627A/ko
Application granted granted Critical
Publication of KR101060331B1 publication Critical patent/KR101060331B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020057007230A 2002-11-06 2003-10-14 인플루엔자 바이러스 감염의 치료에 유용한 약제의 제조를위한 레스베라트롤의 용도 Expired - Lifetime KR101060331B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2002A000562 2002-11-06
IT000562A ITRM20020562A1 (it) 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
PCT/IT2003/000626 WO2004041260A1 (en) 2002-11-06 2003-10-14 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections

Publications (2)

Publication Number Publication Date
KR20050071627A KR20050071627A (ko) 2005-07-07
KR101060331B1 true KR101060331B1 (ko) 2011-08-30

Family

ID=32310188

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057007230A Expired - Lifetime KR101060331B1 (ko) 2002-11-06 2003-10-14 인플루엔자 바이러스 감염의 치료에 유용한 약제의 제조를위한 레스베라트롤의 용도

Country Status (18)

Country Link
US (1) US8431617B2 (enExample)
EP (1) EP1567137B1 (enExample)
JP (1) JP4589118B2 (enExample)
KR (1) KR101060331B1 (enExample)
AR (1) AR041891A1 (enExample)
AT (1) ATE381929T1 (enExample)
AU (1) AU2003279551A1 (enExample)
CA (1) CA2504872C (enExample)
CY (1) CY1107302T1 (enExample)
DE (1) DE60318327T2 (enExample)
DK (1) DK1567137T3 (enExample)
ES (1) ES2295660T3 (enExample)
IT (1) ITRM20020562A1 (enExample)
MX (1) MXPA05004628A (enExample)
PL (1) PL217628B1 (enExample)
PT (1) PT1567137E (enExample)
TW (1) TWI337863B (enExample)
WO (1) WO2004041260A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2626056A1 (en) * 2005-11-18 2007-05-24 Ares Trading S.A. Interferon in influenza
US8629283B2 (en) * 2008-03-06 2014-01-14 Icahn School Of Medicine At Mount Sinai Compounds that modulate negative-sense, single-stranded RNA virus replication and uses thereof
AU2009313657A1 (en) * 2008-11-04 2010-05-14 Metaproteomics, Llc Phytochemical compositions and methods for activating AMP-kinase
WO2010123527A2 (en) * 2008-12-19 2010-10-28 The Regents Of The University Of California Use of epidermal growth factor inhibitors in the treatment of viral infection
KR100950445B1 (ko) 2009-10-26 2010-04-02 주식회사 중앙백신연구소 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
US9096585B2 (en) 2010-05-28 2015-08-04 Icahn School Of Medicine At Mount Sinai Antiviral compounds and uses thereof
US9453017B2 (en) * 2011-09-30 2016-09-27 Vanderbilt University Antiviral therapies with phospholipase D inhibitors
PT2952209T (pt) 2014-06-04 2018-05-09 Alfasigma Spa Formulações homogéneas compreendendo ácidos gordos poliinsaturados ómega-3 (n-3 pufa) e resveratrol para administração oral
SI2952180T1 (sl) 2014-06-04 2017-05-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Trdne formulacije, ki vsebujejo resveratrol in polinenasičene maščobne kisline omega-3 (n-3 PUFA)
EP3120842A1 (en) * 2015-07-20 2017-01-25 Opterion Health AG Peritoneal therapeutic fluid
KR20170039456A (ko) 2015-10-01 2017-04-11 동아대학교 산학협력단 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물
JP2018024592A (ja) * 2016-08-09 2018-02-15 株式会社ブレインヘルス 抗生物質含有組成物
CN108893558B (zh) * 2018-05-24 2022-04-05 江苏海宏制药有限公司 一种桑木液原液抗病毒实验方法以及装置
EP4132277B1 (en) * 2020-04-05 2025-11-26 Mong, Michael Systems and methods for treating coronavirus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001008671A2 (en) * 1999-07-30 2001-02-08 The Procter & Gamble Company Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
DE60015568D1 (de) * 1999-08-13 2004-12-09 Univ Maryland Biotech Inst Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001008671A2 (en) * 1999-07-30 2001-02-08 The Procter & Gamble Company Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses

Also Published As

Publication number Publication date
JP4589118B2 (ja) 2010-12-01
DE60318327T2 (de) 2008-12-18
JP2006507295A (ja) 2006-03-02
AR041891A1 (es) 2005-06-01
PL377557A1 (pl) 2006-02-06
CA2504872A1 (en) 2004-05-21
PT1567137E (pt) 2008-02-19
TWI337863B (en) 2011-03-01
AU2003279551A1 (en) 2004-06-07
EP1567137B1 (en) 2007-12-26
EP1567137A1 (en) 2005-08-31
PL217628B1 (pl) 2014-08-29
TW200501935A (en) 2005-01-16
DK1567137T3 (da) 2008-04-28
WO2004041260A1 (en) 2004-05-21
ITRM20020562A1 (it) 2004-05-07
US20050239906A1 (en) 2005-10-27
US8431617B2 (en) 2013-04-30
CA2504872C (en) 2011-07-05
DE60318327D1 (de) 2008-02-07
MXPA05004628A (es) 2005-09-08
ATE381929T1 (de) 2008-01-15
ES2295660T3 (es) 2008-04-16
CY1107302T1 (el) 2012-11-21
KR20050071627A (ko) 2005-07-07

Similar Documents

Publication Publication Date Title
Zhao et al. A broad-spectrum virus-and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2
KR101060331B1 (ko) 인플루엔자 바이러스 감염의 치료에 유용한 약제의 제조를위한 레스베라트롤의 용도
Yan et al. Luteolin decreases the yield of influenza A virus in vitro by interfering with the coat protein I complex expression
Amatore et al. Influenza virus replication in lung epithelial cells depends on redox‐sensitive pathways activated by NOX4‐derived ROS
Shin et al. Broad‐spectrum antiviral effect of Agrimonia pilosa extract on influenza viruses
Khan et al. SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease
US20180360819A1 (en) Anti-influenza virus agent and screening method for anti-influenza virus agent
Jeong et al. Identification of regulators of the early stage of viral hemorrhagic septicemia virus infection during curcumin treatment
Dörsam et al. The eucalyptus oil ingredient 1, 8-cineol induces oxidative DNA damage
US20220241325A1 (en) Antioxidant and antiviral compositions and methods
Xu et al. Inhibition of peptide BF-30 on influenza A virus infection in vitro/vivo by causing virion membrane fusion
Li et al. Glutamine starvation inhibits snakehead vesiculovirus replication via inducing autophagy associated with the disturbance of endogenous glutathione pool
Guo et al. Axin1: a novel scaffold protein joins the antiviral network of interferon
KR102227147B1 (ko) 이오노포어를 유효성분으로 포함하는 바이러스성 질환의 예방 또는 치료용 보조제
US20240293384A1 (en) Methods and compositions for treatment of covid-19
Yang et al. Exploration of the mechanisms of Callicarpa nudiflora Hook. et Arn against influenza A virus (H1N1) infection
Zhao et al. A broad-spectrum virus-and host-targeting antiviral peptide against SARS-CoV-2 and other respiratory viruses
RU2580305C1 (ru) ПРОТИВОВИРУСНОЕ СРЕДСТВО НА ОСНОВЕ СУХОГО ЭКСТРАКТА ЛИШАЙНИКА Cetraria islandica
Kirkpatrick et al. Inducible lung epithelial resistance requires multisource reactive oxygen species generation to protect against viral infections. mBio 9: e00696-18
Liu et al. Infectious Bronchitis Virus Triggered Caspase-8/Casapase-3/DFNA5-Mediated Pyroptosis in HD11 Cells Via ROS
WO2021229602A1 (en) Use of compounds for treating viral infections
Pareek et al. “Ivermectin”—a key in the bunch of keys to unlock the other activities including educational institutions in COVID-19 pandemic.
Lv et al. Broad‐spectrum antiviral effect of MoringaA‐loaded exosomes against IAV by mediating the GCN5‐TFEB‐autolysosome pathway
CN115243712A (zh) 膜抑制剂在促进针对包膜病毒的疫苗的开发中的用途
Cheang Biological screening for anti-influenza a virus agents

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20050426

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20081008

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20101021

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20110727

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20110823

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20110824

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20140806

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20140806

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20150806

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20150806

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20160809

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20160809

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20170810

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20170810

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20180809

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20180809

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20190808

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20190808

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20200723

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20220725

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20230725

Start annual number: 13

End annual number: 13

PC1801 Expiration of term

Termination date: 20240414

Termination category: Expiration of duration